Cardiovascular Disease

Daily Dose: Morning Exercise Reduces Risk for Cardiovascular Disease
December 06, 2022

Your daily dose of clinical news you may have missed.

Morning Exercise Reduces Risk for Cardiovascular Disease in a New Study of UK Adults
December 05, 2022

Being most physically active in the late morning had a 16% decreased risk of coronary artery disease and a 17% decreased risk of stroke compared to midday.

Daily Dose: ASCVD Risk Reduced by 10% with Diet
December 02, 2022

Your daily dose of clinical news you may have missed.

ASCVD Risk Reduced by 10% with Diet, Greater Drops Seen in Women, Black Adults
December 01, 2022

The therapeutic impact of the dietary lifestyle intervention and the differential effects could have major implications for clinical care and policy, say study authors.

Cardiac Rehab and Primary Care, with PM&R Specialist Jonathan Whiteson, MD
November 30, 2022

"Cardiac rehabilitation is for life," says the NYU Langone Rusk Rehabilitation medical director of cardiac/pulmonary rehab, and he advocates empathy and compassionate understanding.

Baxdrostat in Phase 2 Clinical Trial Proves Effective, Safe in Treatment-resistant Hypertension
November 14, 2022

Baxdrostat shows potential to represent the first new class of antihypertensive agents approved since 2017.

Social Vulnerabilities Linked to Cardiometabolic Risk in Pregnant Women in US, New Study Finds
November 09, 2022

AHA 2022: Study authors say more research is needed to investigate the impact of targeting social determinants of health to improve cardiometabolic risk and mortality in pregnant women.

Sotagliflozin Cuts Risk by >50% for Heart Failure Readmission, CV Death in Phase 3 SOLOIST-WHF Trial
November 09, 2022

In the SOLOIST-WHF trial, risk for HF readmission and CV death were reduced by more than 50% at 30- and 90-days after hospital discharge.

Study: “Worrisome” Changes in Cardiovascular Function Immediately after Vaping, Smoking Traditional Cigarettes
November 04, 2022

AHA 2022: Chronic users of either e-cigarettes or traditional cigarettes had acute changes in cardiovascular function and performed worse on exercise stress testing than never users in new study.

Apixaban May be the Safer DOAC in Afib, Suggests First Large Comparative Analysis
November 04, 2022

Apixaban was associated with up to a 28% lower risk of GI bleeding vs the 3 other direct oral anticoagulants in the first large-scale comparative analysis.